Cargando…
Evaluation of Predict, a prognostic risk tool, after diagnosis of a second breast cancer
BACKGROUND: The UK National Health Service’s Predict is a clinical tool widely used to estimate the prognosis of early-stage breast cancer. The performance of Predict for a second primary breast cancer is unknown. METHODS: Women 18 years of age or older diagnosed with a first or second invasive brea...
Autores principales: | Deng, Zhengyi, Jones, Miranda R, Wolff, Antonio C, Visvanathan, Kala |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10660126/ https://www.ncbi.nlm.nih.gov/pubmed/37773987 http://dx.doi.org/10.1093/jncics/pkad081 |
Ejemplares similares
-
Mortality after second malignancy in breast cancer survivors compared to a first primary cancer: a nationwide longitudinal cohort study
por: Deng, Zhengyi, et al.
Publicado: (2022) -
Weight Gain after Hormone Receptor-Positive Breast Cancer
por: Goyal, Archita, et al.
Publicado: (2022) -
Optimizing Vitamin D Concentrations for Breast Cancer Risk Reduction
por: Stearns, Vered, et al.
Publicado: (2013) -
Do Breast Cancer Cell Lines Provide a Relevant Model of the Patient Tumor Methylome?
por: Cope, Leslie M., et al.
Publicado: (2014) -
Lifestyle factors in Black female breast cancer survivors—Descriptive results from an online pilot study
por: Connor, Avonne E., et al.
Publicado: (2023)